Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy

Publisher: Karger

E-ISSN: 1421-9670|26|1|50-58

ISSN: 0250-8095

Source: American Journal of Nephrology, Vol.26, Iss.1, 2006-04, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract